[Evaluation for antithrombotic agents by a thrombotic model in animals]

Yasuhiro Suzuki1

  • 1Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan. yapplel@hama-med.ac.jp

Summary

Microplasmin reduced brain damage and neurological deficits in an animal stroke model. The study identified the tissue-type plasminogen activator/low-density lipoprotein receptor-related protein/matrix metalloproteinase-3 pathway as a target to mitigate intracranial hemorrhage risk.

Related Concept Videos